AVNS Dividend: Avanos Medical Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

AVNS Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	699	687	673	820	744	714
Revenue Growth (YoY)	3%	2%	-18%	10%	4%	2%
Cost of Revenue	334	306	293	370	380	341
Gross Profit	365	381	379	450	364	373
Selling, General & Admin	316	314	331	339	300	332
Research & Development	22	26	27	30	32	34
Operating Expenses	334	336	372	374	347	419
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-487	-403	-7	65	5	-60
Income Tax Expense	-19	-17	2	14	0	-33
Net Income	-468	-392	-61	50	5	-27
Net Income Growth	-3,220%	543%	-222%	900%	-119%	-40%
Shares Outstanding (Diluted)	46.4	46	46.6	47.3	48.6	47.8
Shares Change (YoY)	-1%	-1%	-1%	-3%	2%	0%
EPS (Diluted)	-10.1	-8.52	-1.32	1.07	0.11	-0.57
EPS Growth	-3,161%	545%	-223%	873%	-119%	-41%
Free Cash Flow	74	82	14	71	66	-22
Free Cash Flow Per Share	1.59	1.78	0.3	1.5	1.35	-0.46
Gross Margin	52.21%	55.45%	56.31%	54.87%	48.92%	52.24%
Operating Margin	4.43%	6.4%	1.04%	9.26%	2.15%	-6.44%
Profit Margin	-66.95%	-57.05%	-9.06%	6.09%	0.67%	-3.78%
Free Cash Flow Margin	10.58%	11.93%	2.08%	8.65%	8.87%	-3.08%
EBITDA	71	89	53	123	54	-4
EBITDA Margin	10.15%	12.95%	7.87%	15%	7.25%	-0.56%
D&A For EBITDA	40	45	46	47	38	42
EBIT	31	44	7	76	16	-46
EBIT Margin	4.43%	6.4%	1.04%	9.26%	2.15%	-6.44%
Effective Tax Rate	3.9%	4.21%	-28.57%	21.53%	0%	55%